BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16327928)

  • 1. Scientific justification for the participation of children and adolescents in HIV-1 vaccine trials in South Africa.
    Jaspan HB; Gray GE; Robinson AK; Coovadia HM; Bekker LG
    S Afr Med J; 2005 Sep; 95(9):685-7. PubMed ID: 16327928
    [No Abstract]   [Full Text] [Related]  

  • 2. Why we don't need a relative risk standard for adolescent HIV vaccine trials in South Africa.
    Slack CM
    Am J Bioeth; 2011 Jun; 11(6):21-2. PubMed ID: 21678209
    [No Abstract]   [Full Text] [Related]  

  • 3. (Un)risky business: adolescents and HIV prevention trials.
    Philpott S
    Am J Bioeth; 2011 Jun; 11(6):17-9. PubMed ID: 21678207
    [No Abstract]   [Full Text] [Related]  

  • 4. A relative standard for minimal risk is unnecessary and potentially harmful to children: lessons from the Phambili trial.
    Nelson RM
    Am J Bioeth; 2011 Jun; 11(6):14-6. PubMed ID: 21678206
    [No Abstract]   [Full Text] [Related]  

  • 5. Stakeholder perspectives on ethical challenges in HIV vaccine trials in South Africa.
    Essack Z; Koen J; Barsdorf N; Slack C; Quayle M; Milford C; Lindegger G; Ranchod C; Mukuka R
    Dev World Bioeth; 2010 Apr; 10(1):11-21. PubMed ID: 19459900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV: a tale of two centres.
    Cherry M
    Nature; 2007 May; 447(7140):26-7. PubMed ID: 17476240
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV Vaccine Trial participation in South Africa - an ethical assessment.
    Moodley K
    J Med Philos; 2002 Apr; 27(2):197-215. PubMed ID: 11961697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative versus absolute standards for everyday risk in adolescent HIV prevention trials: expanding the debate.
    Snyder J; Miller CL; Gray G
    Am J Bioeth; 2011 Jun; 11(6):5-13. PubMed ID: 21678205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More women and adolescents needed in HIV vaccine trials.
    Expert Rev Vaccines; 2004 Oct; 3(5):501-7. PubMed ID: 15485328
    [No Abstract]   [Full Text] [Related]  

  • 10. The potential impact of a moderately effective HIV vaccine with rapidly waning protection in South Africa and Thailand.
    Andersson KM; Stover J
    Vaccine; 2011 Aug; 29(36):6092-9. PubMed ID: 21703322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges to conducting HIV preventative vaccine trials with adolescents.
    McClure CA; Gray G; Rybczyk GK; Wright PF
    J Acquir Immune Defic Syndr; 2004 Jun; 36(2):726-33. PubMed ID: 15167292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The South African Medical Research Council's Guidelines on Ethics for Medical Research--implications for HIV-preventive vaccine trials with children.
    Slack C; Kruger M
    S Afr Med J; 2005 Apr; 95(4):269-71. PubMed ID: 15889852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine trial needs subjects.
    AIDS Patient Care STDS; 2002 May; 16(5):244. PubMed ID: 12058702
    [No Abstract]   [Full Text] [Related]  

  • 14. A qualitative assessment of perspectives on the inclusion of adolescents in HIV vaccine trials in South Africa.
    Jaspan HB; Soka NF; Mathews C; Flisher AJ; Mark D; Middelkoop K; Wood R; Bekker LG
    Int J STD AIDS; 2010 Mar; 21(3):172-6. PubMed ID: 20215620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa.
    Mamotte N; Wassenaar D; Koen J; Essack Z
    BMC Med Ethics; 2010 Mar; 11():3. PubMed ID: 20211030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Executive summary and recommendations from WHO/UNAIDS and AAVP consultation on: 'The inclusion of adolescents in HIV vaccine trials', 16-18 March 2006 in Gaborone, Botswana.
    ; Osmanov S
    AIDS; 2007 Sep; 21(14):W1-10. PubMed ID: 17721089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic HIV vaccines show promise.
    Abbott A
    Nature; 2010 Jul; 466(7306):539. PubMed ID: 20671679
    [No Abstract]   [Full Text] [Related]  

  • 18. Response to Open Peer Commentaries on "Relative versus absolute standards for everyday risk in adolescent HIV prevention trials: expanding the debate".
    Snyder J; Miller CL; Gray G
    Am J Bioeth; 2011 Jun; 11(6):W1-3. PubMed ID: 21678202
    [No Abstract]   [Full Text] [Related]  

  • 19. First candidate enrolled in new HIV vaccine trial.
    Expert Rev Vaccines; 2003 Dec; 2(6):732-3. PubMed ID: 15278999
    [No Abstract]   [Full Text] [Related]  

  • 20. Social and behavioral aspects of child and adolescent participation in HIV vaccine trials.
    Swartz L; Kagee A; Kafaar Z; Smit J; Bhana A; Gray G; Lesch A; Lindegger G; Milford C; Richter L; Seedat S; Skhosana N; Stein DJ
    J Int Assoc Physicians AIDS Care (Chic); 2005 Dec; 4(4):89-92. PubMed ID: 16533797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.